Focus on gastrointestinal and liver cancers

Seminars in Cancer Biology

Volumn 23, Issue 6 PB, 2013, Pages 469-470

  Wu, William K K ^a   Sung, Joseph J Y ^a  

^a LKS Institute of Health Sciences   (China)

Author keywords

Colorectal cancer; Esophageal cancer; Gastric cancer; Liver cancer

Indexed keywords

BEVACIZUMAB; BH3 PROTEIN; CETUXIMAB; MICRORNA;

AUTOPHAGY; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; EDITORIAL; ENTERITIS; GENETIC SUSCEPTIBILITY; HEPATITIS B VIRUS; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; NONHUMAN; RISK FACTOR; STOMACH CANCER; TUMOR MICROENVIRONMENT;

COLORECTAL CANCER; ESOPHAGEAL CANCER; GASTRIC CANCER; LIVER CANCER;

GASTROINTESTINAL NEOPLASMS; HUMANS; LIVER NEOPLASMS;

EID: 84887611843     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2013.09.006     Document Type: Editorial

References (20)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: A Cancer Journal for Clinicians 2011, 61:69-90.
2. Sung J.J., Lau J.Y., Goh K.L., Leung W.K., Asia Pacific Working Group on Colorectal C Increasing incidence of colorectal cancer in Asia: implications for screening. The Lancet Oncology 2005, 6:871-876.
3. Ben Q., An W., Jiang Y., Zhan X., Du Y., Cai Q.C., et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 2012, 142:762-772.
4. Center M.M., Jemal A. International trends in liver cancer incidence rates. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011, 20:2362-2368.
5. White D.L., Kanwal F., El-Serag H.B. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clinical Gastroenterology and Hepatology: The official clinical practice journal of the American Gastroenterological Association 2012, 10:1342-1359. e2.
6. Tian Y., Wong V.W., Chan H.L., Cheng A.S. Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease. Seminars in Cancer Biology 2013.
7. Yu J., Shen J., Sun T.T., Zhang X., Wong N. Obesity, insulin resistance, NASH and hepatocellular carcinoma. Seminars in Cancer Biology 2013.
8. Jemal A., Center M.M., DeSantis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology, Biomarkers & Prevention: A publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010, 19:1893-1907.
9. Shiotani A., Cen P., Graham D.Y. Eradication of gastric cancer is now both possible and practical. Seminars in Cancer Biology 2013.
10. Wong S.H., Sung J.J., Chan F.K., To K.F., Ng S.M., Yu J., et al. Genome-wide association and sequencing studies on colorectal cancer. Seminars in Cancer Biology 2013.
11. Wu W.K., Law P.T., Lee C.W., Cho C.H., Fan D., Wu K., et al. MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis 2011, 32:247-253.
12. Wu W.K., Lee C.W., Cho C.H., Fan D., Wu K., Yu J., et al. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene 2010, 29:5761-5771.
13. Sakai N.S., Samia-Aly E., Barbera M., Fitzgerald R.C. A review of the current understanding and clinical utility of miRNAs in esophageal cancer. Seminars in Cancer Biology 2013.
14. Catalano V., Turdo A., Di Franco S., Dieli F., Todaro M., Stassi G. Tumor and its microenvironment: a synergistic interplay. Seminars in Cancer Biology 2013.
15. Tang J., Li Z., Lu L., Cho C.H. beta-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy. Seminars in Cancer Biology 2013.
16. Kostic A.D., Chun E., Robertson L., Glickman J.N., Gallini C.A., Michaud M., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host & Microbe 2013, 14:207-215.
17. Rubinstein M.R., Wang X., Liu W., Hao Y., Cai G., Han Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host & Microbe 2013, 14:195-206.
18. Liu Z., Cao A.T., Cong Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Seminars in Cancer Biology 2013.
19. Yu L., Liu S. Autophagy contributes to modulating the cytotoxicities of Bcl-2 homology domain-3 mimetics. Seminars in Cancer Biology 2013.
20. Locarnini S., Littlejohn M., Aziz M.N., Yuen L. Possible origins and evolution of the hepatitis B virus (HBV). Seminars in Cancer Biology 2013.